Trial Profile
Clinical and metabolic effects of rosiglitazone plus metformin and metformin only or rosiglitazone only in obese women with polycystic ovary syndrome and metabolic disorders: a randomized controlled trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Apr 2016
Price :
$35
*
At a glance
- Drugs Metformin (Primary) ; Rosiglitazone (Primary)
- Indications Polycystic ovary syndrome
- Focus Therapeutic Use
- 26 Mar 2016 Status changed from not yet recruiting to completed.
- 05 Oct 2013 New trial record